These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 24828516)
1. Platelet CD36 links not only α-granule-derived proteins to thrombus stability but also metabolic and oxidant stress to a prothrombotic phenotype. Silverstein RL Arterioscler Thromb Vasc Biol; 2014 Jun; 34(6):1120-1. PubMed ID: 24828516 [No Abstract] [Full Text] [Related]
2. Supporting roles of platelet thrombospondin-1 and CD36 in thrombus formation on collagen. Kuijpers MJ; de Witt S; Nergiz-Unal R; van Kruchten R; Korporaal SJ; Verhamme P; Febbraio M; Tjwa M; Voshol PJ; Hoylaerts MF; Cosemans JM; Heemskerk JW Arterioscler Thromb Vasc Biol; 2014 Jun; 34(6):1187-92. PubMed ID: 24675658 [TBL] [Abstract][Full Text] [Related]
3. Inflammation, atherosclerosis, and arterial thrombosis: role of the scavenger receptor CD36. Silverstein RL Cleve Clin J Med; 2009 Apr; 76 Suppl 2(Suppl 2):S27-30. PubMed ID: 19376978 [TBL] [Abstract][Full Text] [Related]
4. Signaling role of CD36 in platelet activation and thrombus formation on immobilized thrombospondin or oxidized low-density lipoprotein. Nergiz-Unal R; Lamers MM; Van Kruchten R; Luiken JJ; Cosemans JM; Glatz JF; Kuijpers MJ; Heemskerk JW J Thromb Haemost; 2011 Sep; 9(9):1835-46. PubMed ID: 21696539 [TBL] [Abstract][Full Text] [Related]
5. Thrombospondin-1 promotes hemostasis through modulation of cAMP signaling in blood platelets. Aburima A; Berger M; Spurgeon BEJ; Webb BA; Wraith KS; Febbraio M; Poole AW; Naseem KM Blood; 2021 Feb; 137(5):678-689. PubMed ID: 33538796 [TBL] [Abstract][Full Text] [Related]
6. Advanced glycation end products induce a prothrombotic phenotype in mice via interaction with platelet CD36. Zhu W; Li W; Silverstein RL Blood; 2012 Jun; 119(25):6136-44. PubMed ID: 22431576 [TBL] [Abstract][Full Text] [Related]
10. Involvement of a CD47-dependent pathway in platelet adhesion on inflamed vascular endothelium under flow. Lagadec P; Dejoux O; Ticchioni M; Cottrez F; Johansen M; Brown EJ; Bernard A Blood; 2003 Jun; 101(12):4836-43. PubMed ID: 12609828 [TBL] [Abstract][Full Text] [Related]
11. The microvesicle/CD36 complex triggers a prothrombotic phenotype in patients with non-valvular atrial fibrillation. Wang H; Song NP; Li JP; Wang ZH; Ti Y; Li YH; Zhang W; Zhong M J Cell Mol Med; 2020 Jul; 24(13):7331-7340. PubMed ID: 32510852 [TBL] [Abstract][Full Text] [Related]
12. Regulation of nitric oxide signalling by thrombospondin 1: implications for anti-angiogenic therapies. Isenberg JS; Martin-Manso G; Maxhimer JB; Roberts DD Nat Rev Cancer; 2009 Mar; 9(3):182-94. PubMed ID: 19194382 [TBL] [Abstract][Full Text] [Related]
13. Thrombospondin 1 Triggers Osteosarcoma Cell Metastasis and Tumor Angiogenesis. Jian YK; Zhu HY; Wu XL; Li B Oncol Res; 2019 Feb; 27(2):211-218. PubMed ID: 29540257 [TBL] [Abstract][Full Text] [Related]
14. Thrombospondin-1 inhibits in vitro megakaryocytopoiesis via CD36. Yang M; Li K; Ng MH; Yuen PM; Fok TF; Li CK; Hogg PJ; Chong BH Thromb Res; 2003 Jan; 109(1):47-54. PubMed ID: 12679131 [TBL] [Abstract][Full Text] [Related]
15. A specific CD36-dependent signaling pathway is required for platelet activation by oxidized low-density lipoprotein. Chen K; Febbraio M; Li W; Silverstein RL Circ Res; 2008 Jun; 102(12):1512-9. PubMed ID: 18497330 [TBL] [Abstract][Full Text] [Related]
16. Thrombospondin-1: an inhibitor of angiogenesis. Taraboletti G Haemostasis; 2001; 31 Suppl 1():23-4. PubMed ID: 11990468 [No Abstract] [Full Text] [Related]